The hepatitis B surface antibody test (HBsAb) detects antibodies in the blood to determine if someone is immune to the hepatitis B virus (HBV). A negative or nonreactive result means the individual is ...

Hepatitis B is a viral infection that impacts the liver. To test for hepatitis B, a doctor can perform a blood test that detects hepatitis B surface antigens. A positive result indicates a hepatitis B ...

An announcement from Karolinska Development AB ( ($SE:KDEV) ) is now available. Karolinska Development AB’s portfolio company, SVF Vaccines, has ...

The hepatitis B vaccine can reduce your risk of developing the infection. But up to 10% of people may not respond to this vaccine. They may need to take extra steps to avoid hep B exposure. The ...

The CDC currently says a timely administration of a hepatitis B vaccine is essential to help prevent transmission of the ...

STOCKHOLM, Sweden, October 24, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has presented positive results from a preclinical study of its ...

This large-scale exploratory study demonstrated that the prevalence of HDV antibody positivity was very low (0.24%) in Chinese patients with chronic HBV infection, with only one of the 4,936 patients ...

WARMINSTER, Pa., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a Hepatitis B Virus (HBV) therapeutic solutions company, today announced its decision to discontinue ...